Martingale Asset Management’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$211K Sell
3,714
-353
-9% -$20.1K 0.01% 751
2025
Q1
$228K Buy
4,067
+101
+3% +$5.66K 0.01% 724
2024
Q4
$244K Sell
3,966
-2
-0.1% -$123 0.01% 720
2024
Q3
$266K Buy
3,968
+201
+5% +$13.4K 0.01% 726
2024
Q2
$252K Buy
3,767
+100
+3% +$6.68K 0.01% 719
2024
Q1
$261K Buy
3,667
+301
+9% +$21.4K 0.01% 729
2023
Q4
$283K Hold
3,366
0.01% 713
2023
Q3
$289K Buy
3,366
+5
+0.1% +$430 0.01% 692
2023
Q2
$313K Buy
3,361
+2
+0.1% +$186 0.01% 690
2023
Q1
$318K Hold
3,359
0.01% 699
2022
Q4
$338K Sell
3,359
-19
-0.6% -$1.91K 0.01% 699
2022
Q3
$289K Buy
3,378
+70
+2% +$5.99K 0.01% 715
2022
Q2
$285K Buy
3,308
+2
+0.1% +$172 0.01% 742
2022
Q1
$298K Sell
3,306
-300
-8% -$27K ﹤0.01% 725
2021
Q4
$361K Hold
3,606
﹤0.01% 703
2021
Q3
$336K Buy
+3,606
New +$336K ﹤0.01% 734
2020
Q4
Sell
-10,802
Closed -$863K 1046
2020
Q3
$863K Sell
10,802
-13,200
-55% -$1.05M 0.01% 671
2020
Q2
$2.13M Buy
24,002
+300
+1% +$26.6K 0.03% 511
2020
Q1
$2.23M Buy
23,702
+400
+2% +$37.6K 0.03% 464
2019
Q4
$2.52M Buy
23,302
+200
+0.9% +$21.6K 0.03% 542
2019
Q3
$2.22M Buy
23,102
+600
+3% +$57.5K 0.02% 565
2019
Q2
$2.15M Buy
22,502
+400
+2% +$38.3K 0.02% 575
2019
Q1
$1.95M Buy
22,102
+3,100
+16% +$274K 0.02% 606
2018
Q4
$1.58M Buy
19,002
+1,700
+10% +$141K 0.02% 600
2018
Q3
$1.63M Buy
17,302
+100
+0.6% +$9.42K 0.02% 600
2018
Q2
$1.9M Hold
17,202
0.02% 559
2018
Q1
$1.7M Sell
17,202
-200
-1% -$19.8K 0.02% 574
2017
Q4
$1.42M Buy
17,402
+201
+1% +$16.4K 0.02% 630
2017
Q3
$1.27M Buy
17,201
+6,300
+58% +$464K 0.02% 676
2017
Q2
$790K Buy
10,901
+2,700
+33% +$196K 0.01% 756
2017
Q1
$511K Sell
8,201
-1,400
-15% -$87.2K 0.01% 816
2016
Q4
$699K Buy
9,601
+1,400
+17% +$102K 0.01% 783
2016
Q3
$491K Buy
8,201
+4,300
+110% +$257K 0.01% 812
2016
Q2
$246K Buy
3,901
+400
+11% +$25.2K ﹤0.01% 780
2016
Q1
$219K Buy
+3,501
New +$219K ﹤0.01% 769